All News #Library
Rare Diseases
Mabwell gets NMPA approval for B7-H3 ADC trial with PD-1 inhibitor
02 Apr 2025 //
PR NEWSWIRE
Mabwell to Present 6 studies at 2025 AACR Annual Meeting
26 Mar 2025 //
PR NEWSWIRE
FDA Grants Orphan Drug Designation to 9MW2821
07 May 2024 //
PR NEWSWIRE

Market Place
Sourcing Support